Sign in
4

Changes in Ownership

Passage BIO, Inc. Filed Acc 0001209191-22-033149

Options or other derivatives

  • Interim CEO, GC & Corp. Sec. acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cale Edgar B. Interim CEO, GC & Corp. Sec. 2022-05-31 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D
Loading xslF345X03/doc4.xml…